Literature DB >> 617047

The anti-Müllerian hormone.

N Josso, J Y Picard, D Tran.   

Abstract

Müllerian regression in the male fetus is mediated by a discrete fetal testicular hormone, different from testosterone and synthetized by Sertoli cells. Secretion of AMH begins shortly after testicular differentiation and lasts into the perinatal period; however, the müllerian duct is responsive to AMH only during a short "critical" period at the end of the ambisexual stage. Species-specificity has not been demonstrated in mammals, but avian müllerian ducts do not respond to mammalian AMH, although the mammalian müllerian ducts to respond to avian AMH. Investigations concerning the biochemical nature of AMH have been carried out on incubation media of calf fetal testes. Anti-müllerian activity of the incubation medium is not affected by dialysis, is enhanced by concentration by ultrafiltration and is not correlated with the testosterone content of the medium. Gel filtration of the incubation medium on Sephadex G 200 and Biogel A-5m indicates that the anti-müllerian hormone is a protein of relatively high molecular weight, between 200,000 and 320,000 daltons.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 617047

Source DB:  PubMed          Journal:  Birth Defects Orig Artic Ser        ISSN: 0547-6844


  9 in total

1.  Successful testicular sperm recovery and IVF treatment in a man with Leydig cell hypoplasia.

Authors:  M E Bakircioglu; P Tulay; N Findikli; B Erzik; M Gultomruk; M Bahceci
Journal:  J Assist Reprod Genet       Date:  2014-05-03       Impact factor: 3.412

2.  Comments on some genetic abnormalities of sex determination and sex differentiation in Homo sapiens.

Authors:  J M Opitz
Journal:  Eur J Pediatr       Date:  1980-03       Impact factor: 3.183

Review 3.  Anti-Müllerian hormone: an ovarian reserve marker in primary ovarian insufficiency.

Authors:  Jenny A Visser; Izaäk Schipper; Joop S E Laven; Axel P N Themmen
Journal:  Nat Rev Endocrinol       Date:  2012-01-10       Impact factor: 43.330

4.  Focal Mullerian duct retention in male mice with constitutively activated beta-catenin expression in the Mullerian duct mesenchyme.

Authors:  Pradeep S Tanwar; LiHua Zhang; Yoshihiro Tanaka; Makoto M Taketo; Patricia K Donahoe; Jose M Teixeira
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-30       Impact factor: 11.205

5.  Gonadal dysgenesis in a 46,XY female mosaic for double autosomal trisomies 8 and 21.

Authors:  J M Sulewski; S Ward; R L Ladda
Journal:  J Med Genet       Date:  1980-08       Impact factor: 6.318

6.  Transdifferentiation by defined factors as a powerful research tool to address basic biological questions.

Authors:  Yosef Buganim; Rudolf Jaenisch
Journal:  Cell Cycle       Date:  2012-11-19       Impact factor: 4.534

7.  High Variability of Molecular Isoforms of AMH in Follicular Fluid and Granulosa Cells From Human Small Antral Follicles.

Authors:  Linn Salto Mamsen; Jane Alrø Bøtkjær; Stine Gry Kristensen; Susanne Elisabeth Pors; Janni Vikkelsø Jeppesen; Ajay Kumar; Bhanu Kalra; Erik Ernst; Claus Yding Andersen
Journal:  Front Endocrinol (Lausanne)       Date:  2021-03-02       Impact factor: 5.555

8.  Clinical Utility of Anti-Mullerian Hormone in Pediatrics.

Authors:  Roopa Kanakatti Shankar; Tazim Dowlut-McElroy; Andrew Dauber; Veronica Gomez-Lobo
Journal:  J Clin Endocrinol Metab       Date:  2022-01-18       Impact factor: 5.958

9.  Complete androgen insensitivity syndrome and anti-Müllerian hormone levels before and after laparoscopic gonadectomy.

Authors:  Maki Kusumi; Makiko Mitsunami; Hiroki Onoue; Momo Noma; Fumiko Matsumura; Chisa Tabata; Seiji Tanaka; Noriko Watanabe; Takako Kurosawa; Toshihiro Fujiwara; Osamu Tsutusmi
Journal:  Gynecol Minim Invasive Ther       Date:  2016-12-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.